Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Children With Autism
NCT00183404Phase 3Completed
- Sponsor
- Drexel University
- Start
- Sep 2004
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in Autism Spectrum Disorder (ASD), sponsored by Drexel University. Started Sep 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00183404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183404.